FDA Approved: YARTEMLEA — Original Application (Omeros Corporation)

View source ↗

Summary

FDA approved the original biologics license application for narsoplimab (brand YARTEMLEA) from Omeros Corporation for hematopoietic stem cell transplantation-as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation-associated Thrombotic Microangiopathy

Drugs mentioned

• YARTEMLEA (narsoplimab)

Snippet

ORIG AP for YARTEMLEA (NARSOPLIMAB)